Managing Editor
@ShahidNShah
@ShahidNShah
Building the Business Case for Digital Endpoints in Clinical Trials - DATAcc by DiMe
Digital measures provide unprecedented insights into patients’ symptoms and experiences. By reducing trial costs, improving efficiency, and enhancing outcomes, digital endpoints have the potential to transform clinical research. While digital endpoints have demonstrated substantial potential for generating financial benefits, securing stakeholder buy-in and investment remains challenging without a standardized framework to measure impact and return on investment (ROI).
DATAcc by DiMe has developed resources to help you build a compelling business case for adopting digital endpoints in clinical trials. These resources highlight the value, drivers, demonstrate potential ROI, and equip you with the data needed to unlock the full potential of digital endpoints to improve patient outcomes and the drug development process.
Continue reading at datacc.dimesociety.org
Make faster decisions with community advice
- How an Expert Endodontist in Burien Can Save Your Natural Teeth
- 23andMe Files for Chapter 11 Bankruptcy to Facilitate Sale
- Revolutionizing Hospital Security: How AI-Powered Cameras Enhance Patient Safety
- Empowering Patients with Next-gen Mobility Innovations
- Can You Go to the Hospital for a Dental Emergency in Bendigo? What You Need to Know
Next Article
-
How an Expert Endodontist in Burien Can Save Your Natural Teeth
Preserving natural teeth remains the ideal solution for long-term oral health. Modern endodontic treatments offer patients in Burien advanced alternatives to extraction, even in cases previously …
Posted Mar 25, 2025 Dental Care Dentistry
